![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 209/16 | (2006.01) |
A61P 25/00 | (2006.01) | ||
A61P 25/04 | (2006.01) | ||
A61P 25/06 | (2006.01) | ||
A61P 25/16 | (2006.01) | ||
A61P 25/22 | (2006.01) | ||
A61P 25/24 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61K 31/4045 | (2006.01) |
(11) | Number of the document | 4313945 |
(13) | Kind of document | T |
(96) | European patent application number | 23717046.9 |
Date of filing the European patent application | 2023-03-27 | |
(97) | Date of publication of the European application | 2024-02-07 |
(45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
(46) | Date of publication of the claims translation | 2024-08-26 |
(86) | Number | PCT/EP2023/057882 |
Date | 2023-03-27 |
(87) | Number | WO 2023/186834 |
Date | 2023-10-05 |
(30) | Number | Date | Country code |
22000081 | 2022-03-27 | EP |
(72) |
NORTHEN, Julian , GB
MOORE, Gillian , GB
PARKER, Jake , GB
|
(73) |
GH Research Ireland Limited ,
Joshua Dawson House Dawson Street, Dublin 2 D02 RY95,
IE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kristalinė 5-MeO-DMT hidrobromido druska |
CRYSTALLINE HYDROBROMIDE SALT OF 5-MEO-DMT |
Payment date | Validity (years) | Amount | |
2025-03-05 | 3 | 81.00 EUR |
2026-03-27 |